The Impact Of The Study Design Submitted For The Early Benefit Assessment On The Pricing For Oncologic Drugs
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.389
https://www.valueinhealthjournal.com/article/S1098-3015(17)30723-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
366
First Page :
A467
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30723-4&doi=10.1016/j.jval.2017.08.389